Anthropic, one of the two artificial-intelligence labs dictating the fortunes of America’s stock markets, lists on Tuesday, November 18, at a valuation yet to be settled — while OpenAI, its larger rival, remains private, a pairing that captures why American startups still go public, eventually, despite the drag of regulation.
The awkward fact, as The Economist reported on Monday, is that the two companies steering market sentiment are not traded on the exchanges they influence. OpenAI has raised vast sums without listing; its chief executive Sam Altman said in September that going public now would be “ill-advised”.
Anthropic, by contrast, had to file a 400-page prospectus before its debut — one that warns investors, The Economist noted, that human existence as well as their money is at risk.
Why does any of this matter to your portfolio? Because the IPO drought has reshaped where returns are made. Fewer listings mean public investors miss the growth phase of companies like OpenAI, which raised $170bn across three funding rounds between October 2024 and March 2026, each round larger than the last, according to the reporting carried by Hindustan Times.
“Heightened public scrutiny” may be “driving companies from the public markets”, wrote Jamie Dimon, boss of JPMorgan Chase, a few years ago — a view Anthropic’s cumbersome debut does little to dispel.
Private capital drives decline in firm listings
- Regulation is not the villain: a study by Michael Ewens of Columbia University and co-authors calculates regulatory burdens explain only 7% of the decline since 2000 in private firms’ probability of listing.
- Abundant private capital is the likelier cause, argues Ludovic Phalippou of Oxford University — startups can now assemble hefty sums from a few big benefactors.
- Companies are waiting longer: the median age at IPO has risen from eight years in 1980-2000 to 11 years in 2001-25.
The scarcity of new listings, in numbers
The headline statistics look alarming. In 1996 some 8,000 firms were listed in America; after decades of delistings, the count is now half that. Between 1980 and 2000 an average of 310 firms went public each year. Between 2001 and 2025 the annual figure fell to 113.
The calculation, however, changes the story. The delisting count ignores mergers. When two listed firms combine, the number of public companies falls, yet most of the underlying assets and operations remain. And when a listed firm buys an unlisted one, stock investors gain exposure to the acquired business anyway.
After adjusting for corporate marriages, the decline in American listings between 1996 and 2020 disappears, according to a paper by B. Espen Eckbo and Markus Lithell, two academics, cited in The Economist’s report. The same is not true in other rich countries, where listings have fallen even after adjusting for mergers.
Costly regulation, or comfortable privacy?
The conventional explanation holds that private markets grew more dynamic while public markets turned cumbersome. Rules like the Sarbanes-Oxley Act, passed in 2002, require firms to keep extensive documentation on their inner workings. Paul Atkins, America’s top securities regulator, blames such burdens for discouraging debutantes and has promised to “make IPOs great again”, including by exempting hundreds of firms from SOX’s stiffest strictures.
But the balance sheet tells a different story. The costs of going public are real yet do not look prohibitive — regulation accounts for just 7% of the diminished listing probability, per the Ewens study. SOX alone barely registers.
The more likely culprit is capital abundance. The point of public markets is to let firms aggregate large amounts of capital from a wide investor base. Institutional investors have ploughed so much cash into America’s private markets that startups can piece together comparable sums from a few large backers. Some finance houses now speak of “private IPOs”. Private fundraising also lets early employees cash out shares, reducing urgency to list.
Cash-burning startups gain another perk: repeated rounds raised in quick succession — “a pattern of financing that public markets handle poorly”, as Phalippou points out in a recent working paper. OpenAI’s $170bn in three escalating rounds between October 2024 and March 2026 is the case in point.
| Company / metric | Figure | Context |
|---|---|---|
| OpenAI private fundraising | $170bn | Three rounds, Oct 2024–Mar 2026, each bigger than the last |
| SpaceX valuation at listing | $1.8trn | Listed this year at age 20-something |
| Median IPO age | 8 → 11 years | 1980-2000 vs 2001-25 |
| Annual US IPOs | 310 → 113 | 1980-2000 average vs 2001-25 average |
| Regulatory share of listing decline | 7% | Ewens et al., decline since 2000 |
What public markets are pricing in
The contrast with listed peers is stark. When Alphabet announced in June it would issue $80bn in fresh equity, its share price fell by 4% the next day, wiping $170bn off its market capitalisation. Public companies must pay steep fees to investment banks and endure market scrutiny that often registers displeasure when firms say they need more capital. Private founders face no such verdict.
SpaceX shows the other end of the trade-off: it was a 20-something company before listing this year at a valuation of $1.8trn — by which point much of the early growth had already accrued to private investors.
So why list at all? Anthropic’s debut on Tuesday answers it: liquidity for employees and early backers, a currency for acquisitions, and access to the widest capital pool that exists. Privacy delays the reckoning; it does not remove it. Even at $1.8trn, SpaceX eventually faced the public tape.
Where the listing pipeline goes from here
Watch two things. First, whether Atkins’s promised SOX exemptions move the annual IPO count above its 113-firm average — if regulation is only 7% of the problem, deregulation should move the needle modestly.
Second, how Anthropic’s unsettled valuation is received on its first day of trading; a strong debut would remind late-stage startups that public markets still pay for AI exposure, while a weak one would validate Altman’s judgment that listing now is “ill-advised”.
The structural trend, on the current evidence, is toward later, larger debuts rather than none at all. The median listing age has already stretched from eight years to 11. Anthropic goes public on Tuesday; the question is not whether startups go public, but how much growth private investors get to keep first.
Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute financial advice.
Worth a look
- Hopkins Man Charged with Attempted Murder and Carjacking in Brutal Attack on Somali-American Uber Driver
- US Bishops Vote to Advance Sainthood Cause for Pennsylvania Teen Maria Middleton
- 3.6% for Social Security, 2.6% for FERS, and a Bill Still Pending for VA (daybreakwire.com)
- Chicago Opens City’s First Self-Cleaning Public Toilet (news-usa.today)